Valneva provides regulatory update on its covid-19 vaccine candidate

Saint herblain (france), march 1 1 , 202 2 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today provided an update on the regulatory review of its inactivated, covid-19 vaccine candidate, vla2001, by the committee for medicinal products for human use (chmp) of the european medicines agency (ema).
VALN Ratings Summary
VALN Quant Ranking